Rescue coronary stenting with heparin-coated Jostents for failed thrombolysis in acute XXXX .

@entity1 @entity548 @entity256 @entity177 @entity1188 @entity453 @entity583 @entity1455 @entity715
The aim of the present study was to assess the procedural safety and in-hospital and long-term effectiveness of heparin-coated Jostents after failed thrombolysis in acute @entity583 . We prospectively analyzed the acute and long-term clinical and angiographic outcomes of 35 consecutive @entity1 treated with heparin-coated Jostents for @entity177 . Rescue coronary stenting was successful in 34 of 35 @entity1 (97%). Thrombolysis in Myocardial Infarction flow grade 3 was obtained in 31 @entity1 (88.5%). The only @entity1 with procedural failure died from @entity1455 a day after the procedure. One @entity1 (2.8%) underwent an emergency coronary bypass operation because of angiographic evidence of stent @entity715 with re- @entity1188 . During in-hospital follow-up, 2 @entity1 (5.7%) underwent an elective coronary bypass operation after successful stent implantation of the @entity1188 because of existing severe multivessel @entity453 . Minor @entity548 complications at the vascular access site occurred in 3 (8.6%) @entity1 . No cerebrovascular or any other major @entity548 complication occurred. One @entity1 (2.1%) underwent repeat coronary angioplasty for @entity256 and an elective coronary artery bypass operation was performed in one @entity1 (2.8%) during the 294 +/- 150 days follow-up. The rate of target vessel revascularization was 14.3% and the event-free survival rate was 80%. Twenty-six @entity1 (90%) had angiographic follow-up at six months, and stent @entity256 was found in 5 (19.2%). This study demonstrates that heparin-coated Jostents are sale, with low in-hospital and long-term mortality rates for the treatment of failed thrombolysis in acute @entity583 . The angiographic @entity256 and target vessel revascularization rates of this registry are also acceptable.
